{
"NDC": {
"NDCCode": "67877-730-05",
"PackageDescription": "500 TABLET in 1 BOTTLE (67877-730-05) ",
"NDC11Code": "67877-0730-05",
"ProductNDC": "67877-730",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Roflumilast",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Roflumilast",
"DosageFormName": "TABLET",
"RouteName": "ORAL",
"StartMarketingDate": "20250314",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA212490",
"LabelerName": "Ascend Laboratories, LLC",
"SubstanceName": "ROFLUMILAST",
"StrengthNumber": "250",
"StrengthUnit": "ug/1",
"Pharm_Classes": "Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2025-03-15",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20250314",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}